Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

The advanced heart failure market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical companies such as ...

It's CeraVe-time to celebrate! CeraVe, the global skincare brand recommended by 80,000 dermatologists worldwide1, is ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...

In the rapidly evolving landscape of nuclear medicine, the integration of diagnostics and therapeutics - known as ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Therapeutics Market, valued at approximately USD 143.95 billion in 2023, is projected to witness strong expansion over the forecast period, reaching an estimated valuation exceeding USD 270 billion by ...

Q2 2025 Earnings Call Transcript July 22, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $2.81, expectations were $2.77. Operator: Ladies and gentlemen, thank you for standing ...

According to Research by SNS Insider, U.S. Basal Cell Carcinoma Treatment Market Growth is Driven by Aging Population and Technological Advancements in Dermatological Care.Austin, July 23, 2025 (GLOBE ...

Rakovina Therapeutics Inc. ("Rakovina” or the "Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered ...

In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...